Dr Lan Gao





Faculty of Health


School of Health & Soc. Dev.


Melbourne Burwood Campus


+61 3 924 45533


Filter by


Cost-effectiveness analysis of lipegfilgrastim as primary prophylaxis in women with breast cancer in Australia: a modelled economic evaluation

Lan Gao, Shu-Chuen Li

(2018), pp. 1-10, Breast cancer, Berlin, Germany, C1


Economic evaluation of a randomized controlled trial of an intervention to reduce office workers' sitting time: the 'Stand Up Victoria' trial

Lan Gao, Anna Flego, David Dunstan, Elisabeth Winkler, Genevieve Healy, Elizabeth Eakin, Lisa Willenberg, Neville Owen, Anthony LaMontagne, Anita Lal, Glen Wiesner, Nyssa Hadgraft, Marj Moodie

(2018), Vol. 44, pp. 503-511, Scandinavian journal of work, environment and health, Helsinki, Finland, C1


Effects and costs of real-time cardiac telerehabilitation: randomised controlled non-inferiority trial

Ralph Maddison, Jonathan Rawstorn, Ralph Stewart, Jocelyne Benatar, Robyn Whittaker, Anna Rolleston, Yannan Jiang, Lan Gao, Marj Moodie, Ian Warren, Andrew Meads, Nicholas Gant

(2018), Heart, London, Eng., C1


Cost-effectiveness of a lifestyle modification program in long-term survivors of hemopoietic stem cell transplantation

L Gao, M Moodie, V Brown, S Avery

(2017), Vol. 31, pp. 1-10, Clinical transplantation, Chichester, Eng., C1


The cost-effectiveness of the online MindSpot Clinic for the treatment of depression and anxiety in Australia

Y-C Lee, L Gao, B Dear, N Titov, C Mihalopoulos

(2017), Vol. 20, pp. 155-166, Journal of mental health policy and economics, Milano, Italy, C1


Can the direct medical cost of chronic disease be transferred across different countries? Using cost-of-illness studies on type 2 diabetes, epilepsy and schizophrenia as examples

L Gao, H Hu, F-L Zhao, S-C Li

(2016), Vol. 11, pp. 1-17, PLoS one, San Francisco, Calif., C1


Emerging drugs for partial-onset epilepsy: a review of brivaracetam

L Gao, S Li

(2016), Vol. 12, pp. 719-734, Therapeutics and clinical risk management, Macclesfield, Eng., C1


Scaling-up an efficacious school-based physical activity intervention: study protocol for the 'Internet-based professional learning to help teachers support activity in youth' (iPLAY) cluster randomized controlled trial and scale-up implementation evaluation

C Lonsdale, T Sanders, K Cohen, P Parker, M Noetel, T Hartwig, D Vasoncellos, M Kirwan, P Morgan, J Salmon, M Moodie, H McKay, A Bennie, R Plotnikoff, R Cinelli, D Greene, L Peralta, D Cliff, G Kolt, J Gore, L Gao, D Lubans

(2016), Vol. 16, pp. 1-16, BMC public health, London, Eng., C1


Burden of epilepsy: a prevalence-based cost of illness study of direct, indirect and intangible costs for epilepsy

L Gao, L Xia, S Pan, T Xiong, S Li

(2015), Vol. 110, pp. 146-156, Epilepsy research, Amsterdam, The Netherlands, C1-1


Efficacy and safety of thrombin-receptor antagonist (atopaxar and vorapaxar) in patients with acute coronary syndrome or coronary artery disease-a meta-analysis of randomized controlled trials

L Gao, F Zhao, S Li

(2015), pp. 22-32, Value in health regional issues, Amsterdam, The Netherlands, C1


Health-related quality of life and willingness to pay per quality-adjusted life-Year threshold-A study in patients with epilepsy in China

L Gao, L Xia, S-Q Pan, T Xiong, S-C Li

(2015), Vol. 6, pp. 89-97, Value in health regional issues, Amsterdam, The Netherlands, C1-1


Adding a new anticoagulant or antiplatelet agent for patient receiving aspirin after an acute coronary syndrome? - Results from a pairwise and network meta-analysis of randomized-controlled trials

L Gao, S-C Li

(2014), Vol. 6, pp. 173-199, British journal of medicine and medical research, West Bengal, India, C1


Psychometric properties of Chinese language Liverpool Seizure Severity Scale 2.0 (LSSS 2.0) and status and determinants of seizure severity for patients with epilepsy in China

L Gao, L Xia, S-Q Pan, T Xiong, S-C Li

(2014), Vol. 31, pp. 187-193, Epilepsy & Behavior, Amsterdam, The Netherlands, C1-1


Validation of the Chinese version of the NUCOG cognitive screening tool in patients with epilepsy, dementia and other neurological disorders

L Gao, S-C Li, L Xia, S Pan, D Velakoulis, M Walterfang

(2014), Vol. 21, pp. 980-987, Journal of clinical neuroscience, Amsterdam, The Netherlands, C1-1


Reliability and validity of QOLIE-10 in measuring health-related quality of life (HRQoL) in Chinese epilepsy patients

L Gao, L Xia, S-Q Pan, T Xiong, S-C Li

(2014), Vol. 108, pp. 565-575, Epilepsy research, Amsterdam, The Netherlands, C1-1


Validation of a Chinese version of the Quality of Well-Being Scale-Self-Administered (QWB-SA) in patients with epilepsy

L Gao, L Xia, S-Q Pan, T Xiong, S-C Li

(2013), Vol. 54, pp. 1647-1657, Epilepsia, Hoboken, N.J., C1-1


Clinical efficacy and safety of the newer antiepileptic drugs as adjunctive treatment in adults with refractory partial-onset epilepsy: a meta-analysis of randomized placebo-controlled trials

L Gao, L Xia, F-L Zhao, S-C Li

(2013), Vol. 103, pp. 31-44, Epilepsy research, Amsterdam, The Netherlands, C1-1


Burden of disease studies in the asia-pacific region: are there enough being performed to provide information for evidence-based health policy?

F Zhao, L Gao, S Li

(2013), Vol. 2, pp. 152-159, Value in health regional issues, Amsterdam, The Netherlands, C1-1


Statin is a reasonable treatment option for patients with Polycystic Ovary Syndrome: a meta-analysis of randomized controlled trials

L Gao, F-L Zhao, S-C Li

(2012), Vol. 120, pp. 367-375, Experimental and clinical endocrinology & diabetes, Stuttgart, Germany, C1-1


Cost-utility analysis of liraglutide versus glimepiride as add-on to metformin in type 2 diabetes patients in China

L Gao, F-L Zhao, S-C Li

(2012), Vol. 28, pp. 436-444, International journal of technology assessment in health care, Cambridge, Eng., C1-1


Funded Projects at Deakin

Australian Competitive Grants

A 21st Century Approach for Improving Self-Management of Heart Disease

Prof Ralph Maddison, Prof Kylie Ball, Prof Brian Oldenburg, Prof Sarah McNaughton, Dr Jonathan Rawstorn, Dr Karen Lamb, Dr Lan Gao, A/Prof Chris Neil, Dr John Amerena, Prof Marj Moodie, Dr Voltaire Nadurata, Prof Clara Chow

NHMRC Project Grant

  • 2018: $381,552

Other Public Sector Funding

The provision of a Health Technology Assessment (HTA) Panel 108/1415

A/Prof Silva Zavarsek, Ms Sandra Younie, Ms Elena Gospodarevskaya, Ms Liliana Bulfone, Dr Lan Gao, Prof Rob Carter

  • 2019: $18,000
  • 2018: $490,336
  • 2017: $361,792
  • 2016: $470,947
  • 2015: $42,000

Industry and Other Funding

Economic Evaluation of the MindSpot Virtual Clinic

Prof Cathy Mihalopoulos, Dr Lan Gao, Ms Yu-Chen Lee

  • 2015: $46,040
  • 2014: $20,000


No completed student supervisions to report